Selected article for: "general population and potential risk"
Author: Magro, Fernando; Abreu, Candida; Rahier, Jean-François
Title: The daily impact of COVID-19 in gastroenterology
  • Cord-id: 8dlqow9n
  • Document date: 2020_4_11
    • ID: 8dlqow9n
    Snippet: A new strain of coronavirus, called SARS-CoV-2, emerged in Wuhan, China, in December 2019, probably originating from a wild-animal contamination. Since then, the situation rapidly evolved from a cluster of patients with pneumonia, to a regional epidemic and now to a pandemic called COrona VIrus Disease 2019 (COVID-19). This evolution is related to the peculiar modes of transmission of the disease and to the globalization and lifestyle of the 21st century that created the perfect scenario for vir
    Document: A new strain of coronavirus, called SARS-CoV-2, emerged in Wuhan, China, in December 2019, probably originating from a wild-animal contamination. Since then, the situation rapidly evolved from a cluster of patients with pneumonia, to a regional epidemic and now to a pandemic called COrona VIrus Disease 2019 (COVID-19). This evolution is related to the peculiar modes of transmission of the disease and to the globalization and lifestyle of the 21st century that created the perfect scenario for virus spread. Even though research has not evidenced particular susceptibility of inflammatory bowel disease (IBD) patients to SARS-CoV-2 infection, immunosuppressive and immunomodulatory treatments were considered potential risk factors. In this context, initiating treatments with these agents should be cautiously weighted and regular ongoing treatments shall be continued, while the dose of corticosteroids should be reduced whenever possible. Due to the increased risk of contamination, elective endoscopic procedures and surgeries should be postponed and IBD online appointments shall be considered. IBD patients shall also follow the recommendations provided to the general population, such as minimization of contact with infected or suspected patients and to wash hands frequently. In the absence of effective treatments and vaccines, this pandemic can only be controlled through prevention of SARS-CoV-2 transmission with the main objectives of providing patients the best healthcare possible and reduce mortality.

    Search related documents:
    Co phrase search for related documents
    • acid production and acute pneumonia: 1
    • acid production and acute respiratory infection: 1
    • acid production and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acid production and liver cirrhosis: 1, 2
    • acid production and liver disease: 1, 2, 3
    • active severe and acute ards respiratory distress syndrome: 1, 2
    • active severe and acute pneumonia: 1, 2, 3, 4, 5, 6
    • active severe and acute respiratory infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • active severe and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48
    • active severe and liver failure: 1
    • active severe and long severe: 1
    • active severe and low respiratory: 1
    • active severe and low respiratory tract: 1
    • active severe infection and acute pneumonia: 1
    • active severe infection and acute respiratory infection: 1, 2, 3, 4, 5, 6, 7, 8
    • active severe infection and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • active severe infection and long severe: 1
    • active severe infection and low respiratory: 1
    • active severe infection and low respiratory tract: 1